SCHEMBL10604698

SCHEMBL10604698

CC(C)=C(F)C(=O)O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26929225 0.79
SCHEMBL988834 0.76 CA1 (0.36)
SCHEMBL14690127 0.76 CA1 (0.36)
SCHEMBL988835 0.76 CA1 (0.36)
SCHEMBL15545780 0.76 FFAR3 (0.38)
SCHEMBL15545779 0.76 FFAR3 (0.38)
SCHEMBL9156418 0.72 LDHA (0.33)
SCHEMBL9156417 0.72 LDHA (0.33)
Oxalic Acid SCHEMBL27704942 0.72 FFAR3 (0.50)
SCHEMBL15588563 0.71

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 41 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-113105475-B Inhibitors of bruton's tyrosine kinase and methods of use thereof 詹森药业有限公司 2022-09-09 CN disclosed
CN-113105475-A Inhibitors of bruton's tyrosine kinase and methods of use thereof 詹森药业有限公司 2021-07-13 CN disclosed
US-10822348-B2 Inhibitors of Bruton's tyrosine kinase and methods of their use JANSSEN PHARMACEUTICA NV (BE) 2020-11-03 US disclosed
US-10822348-B2 Inhibitors of Bruton's tyrosine kinase and methods of their use JANSSEN PHARMACEUTICA NV (BE) 2020-11-03 US disclosed
US-10800792-B2 Inhibitors of Bruton's tyrosine kinase and method of their use JANSSEN PHARMACEUTICA NV (BE) 2020-10-13 US disclosed
US-10800792-B2 Inhibitors of Bruton's tyrosine kinase and method of their use JANSSEN PHARMACEUTICA NV (BE) 2020-10-13 US disclosed
US-10689396-B2 Inhibitors of Bruton's tyrosine kinase and methods of their use JANSSEN PHARMACEUTICA NV (BE) 2020-06-23 US disclosed
US-10689396-B2 Inhibitors of Bruton's tyrosine kinase and methods of their use JANSSEN PHARMACEUTICA NV (BE) 2020-06-23 US disclosed
US-20190284204-A1 INHIBITORS OF BRUTON'S TYROSINE KINASE AND METHOD OF THEIR USE JANSSEN PHARMACEUTICA NV (BE) 2019-09-19 US disclosed
US-20190284204-A1 INHIBITORS OF BRUTON'S TYROSINE KINASE AND METHOD OF THEIR USE JANSSEN PHARMACEUTICA NV (BE) 2019-09-19 US disclosed
US-20150196585-A1 COMPOSITIONS COMPRISING CROSSLINKED CATION-BINDING POLYMERS AND USES THEREOF VIFOR (INTERNATIONAL) LTD. (CH) 2015-07-16 US disclosed
US-20150183908-A1 COMPOSITIONS COMPRISING CROSSLINKED CATION-BINDING POLYMERS AND USES THEREOF VIFOR (INTERNATIONAL) LTD. (CH) 2015-07-02 US disclosed
EP-2874633-A1 COMPOSITIONS COMPRISING CROSSLINKED CATION-BINDING POLYMERS Relypsa, Inc. (US) 2015-05-27 EP disclosed
EP-2867229-A1 PYRROLIDINE DERIVATIVES AND THEIR USE AS COMPLEMENT PATHWAY MODULATORS Novartis AG (CH) 2015-05-06 EP disclosed
WO-2014015244-A1 COMPOSITIONS COMPRISING CROSSLINKED CATION-BINDING POLYMERS SORBENT THERAPEUTICS, INC. (US) 2014-01-23 WO disclosed
WO-2014015240-A1 COMPOSITIONS COMPRISING CROSSLINKED CATION-BINDING POLYMERS SORBENT THERAPEUTICS, INC. (US) 2014-01-23 WO disclosed
WO-2014002052-A1 PYRROLIDINE DERIVATIVES AND THEIR USE AS COMPLEMENT PATHWAY MODULATORS NOVARTIS AG (CH) 2014-01-03 WO disclosed
WO-2014002052-A1 PYRROLIDINE DERIVATIVES AND THEIR USE AS COMPLEMENT PATHWAY MODULATORS NOVARTIS AG (CH) 2014-01-03 WO disclosed
EP-0170842-B1 N-BENZYLCYCLOPROPANECARBOXAMIDE DERIVATIVES, PROCESS FOR THEIR PREPARATION AND FUNGICIDES FOR AGRICULTURE AND HORTICULTURE NIHON TOKUSHU NOYAKU SEIZO K.K. (JP) 1989-09-13 EP disclosed
EP-0170842-A1 N-benzylcyclopropanecarboxamide derivatives, process for their preparation and fungicides for agriculture and horticulture NIHON TOKUSHU NOYAKU SEIZO K.K. (JP) 1986-02-12 EP disclosed